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Screening for Colorectal Cancer in 
Defunctioned Colons 
 
Aims:  Population-based colorectal (bowel) cancer (CRC) screening using faecal occult blood 
tests (FOBT) leads to a reduction in cause-specific mortality. However in patients where the 
colon is defunctioned, the use of standard FOBT is not appropriate. The aim of this study was 
to examine the current trends of clinical practice for colorectal cancer screening in people 
with defunctioned colons. 
 
 
Methods:  An online survey was performed using SurveyMonkey. All members of 
Association of Coloproctology of Great Britain and Ireland (ACPGBI) were invited by email to 
participate.  Further reminders were sent to non responders and partial responders till six 
weeks. All responses were included in our analysis. 
 
Results:  There were 206 (34.59%) questionnaires completed with all questions answered in 
110 (55.8%).  94 (85.4%) responders were colorectal consultant surgeons. 72% of responders 
had worked in their current capacity for more than 5 years. 105 (50.9 %) of the responders 
had encountered CRC in defunctioned colons during their career. 72.2% of responders stated 
that a screening test for colorectal cancer in patients with defunctioned colons is currently 
not offered or they do not know if it is offered or not in their area. 
 
Conclusions:  Bowel screening in the UK is currently not offered to 72.2% of age appropriate 
population with defunctioned colons. 50% of responding colorectal surgeons have 
encountered CRC in such patients. There is considerable variability in clinical practice with 
regards to the optimal age for onset of screening, time interval and the optimal modality to 
offer for screening in such cases. 
  
  
  
Introduction 
 
Colorectal cancer is the fourth most common cause of cancer related death in world 
1-5. with around  41,000 new cases a year in the United Kingdom4-5. It is well 
established that early colorectal cancer is associated with improved survival and 
randomised trials have demonstrated that colorectal cancer screening can reduce 
disease specific mortality in the population offered screening 6-8. 
 
A range of screening modalities have been investigated with varying acceptability 
and cost effectiveness. Currently in the UK, bowel cancer screening is performed 
with the guaiac Faecal Occult blood Test  (gFOBT) and and recently, a change to 
Faecal Immunochemical Testing for haemoglobin (FIT) as the primary test has been 
agreed by the UK  NHS Bowel Cancer Screening Programmes.  
 
However, both FIT and gFOBT based screening requires faecal samples and in those 
patients where a reasonable length of colon has been defunctioned i.e with a 
defunctioning ileostomy or colostomy this screening test is not appropriate.  
 
Non-specific inflammation of the colon is a well described phenomenon following 
diversion of faecal stream in the segment of colon downstream.  The histological 
changes of diversion colitis include diffuse inflammation, crypt architectural 
distortion, crypt abscesses or atrophy, and lymphoid follicular hyperplasia 9-11. The 
incidence of defunctioning colitis is reported to be approximately 70-100%. However 
to date there is no evidence that faecal diversion  without any coexisting 
predisposing factor for colorectal cancer increases the risk for development of 
colorectal cancer in the segment of colon downstream. The incidence of colorectal 
cancer in defunctioned colons is poorly reported in the literature.  
 
Patients may be left with a defunctioned colon for several reasons. The most 
common reason would be rectal cancer surgery. A recent Dutch study has reported 
that 70 % of patients undergoing low anterior resection undergo temporary 
ileostomies 12. A contemporary retrospective study has reported that one in four 
temporary ileostomies performed during anterior resections were never be closed 
  
due various reasons such as anastomotic leak, rectovaginal fistula and disease 
progression. 13 Another important group of the patients include people with 
functional bowel disorders with long term ileostomy or colostomy. The prevalence of 
patients with defunctioned colons is not well known but it is likely that most health 
care professionals will encounter this clinical situation. The practice of offering 
screening for colorectal cancer in these people is variable and to date there are no 
guidelines which can help in decision making process. 
 
The aim of this study was to examine the current trends of clinical practice for 
colorectal cancer screening in asymptomatic people with defunctioned colons. 
  
  
Methods 
 
 
A ten question survey assessing the current awareness and practice of colorectal 
surgeons about the screening for colorectal cancer in people with defunctioned 
colons was generated (Table 1). All questions of questionnaire consisted of multiple 
choice questions with an option for additional information if the participants wished 
so. The questionnaire also examined the region of their clinical practice and duration 
of their experience in the relevant capacity.  
 
The questionnaire was distributed to the members of Association of Coloproctology 
of Great Britain and Ireland (ACPGBI) whose email addresses were listed on the 
website of the ACPGBI The survey was then distributed via SurveyMonkey 
(www.surveymonkey.com). Further email reminders were sent to partial and non 
responders until six weeks had elapsed. Respondent data were deidentified, and all 
responses were collected anonymously. Descriptive statistical analysis was 
performed using software within the SurveyMonkey analytics and using Microsoft 
Excel (Redmond, WA). Institutional review board approval was not obtained for this 
study but was performed based on the guidelines set forth in the Declaration of 
Helsinki. All responses were included in analysis.
  
Results 
 
596 ACPGBI members were invited to participate in the survey study. 206 of those 
invited responded (34.5%). Complete responses to all parts of the questionnaire 
were received in 110 participants. These participants answered all the relevant 
questions from the questionnaire.  
80.0% of the respondents were working in England, 9.1% in Scotland, 4.5% in Wales 
and 3.6% were working in Ireland. 2.7% of responders were working in rest of the 
world.  
 
85.5% of respondents were consultants, 6.3% were speciality doctors and staff 
grades whereas 8% were other members of ACPGBI. 72% of the respondents had 
worked in their current capacity for more than 5 years. 
Experience of colorectal cancer in patients with defunctioned colon was reported by 
105 participants.  
 
Screening incidence 
31 (28.2%) participants stated that a screening test for colorectal cancer was offered 
to people within the screening age range with defunctioned colons. 42 (38.8%) 
responders offered no screening. 37 (33.6%) did not know if it was offered in their 
area of clinical practice. 
 
Screening test recommended 
54 (49.1%) responders did not know at what age to offer a screening test. 15 (13%) 
stated that they would recommend a test in participants aged 50-54 and 14 (12.7%) 
would offer the screening at 60-64 years of age. 64 (58.2%) would offer colonoscopy 
while 24 (22%) would consider flexible sigmoidoscopy. CT colonography was the test 
of choice in 19.1% (n=21).  
 
Screening Interval 
41 (37%) of responders did not know how often they should offer screening. 34 
(30%) stated that they would offer a screening every 5 years.  
  
Discussion 
 
This study demonstrates that colorectal cancer screening in people with a 
defunctioned colon is not performed in majority of the cases in UK. 
Defunctioning stomas (i.e. defunctioning ileostomy or transverse loop colostomy) 
are used for a variety of purposes in the management of benign and neoplastic 
colorectal diseases.  Colorectal surgeons and, to a lesser extent  general practitioners 
will come across patients with a long term defunctioning stoma with an appreciable 
length of colon which is not in functional continuity with the gastrointestinal tract 
not infrequently. There is however, no evidence base on which to base a decision on 
whether or not to offer screening, and what test to advise. 
 
To our knowledge, this is the first study to describe the attitudes and clinical practice 
of colorectal surgeons to bowel cancer screening in a population with defunctioned 
colons. Most  respondents were of the opinion that colorectal cancer screening in 
people with defunctioned colon is either not offered or they do not know if it is 
offered in their area of clinical practice.  
The incidence of colorectal cancer in defunctioned colon is poorly reported. In this 
study 105 respondents reported that they had seen a total of 115 cases of colorectal 
cancer in the defunctioned segment of colon but on literature review the authors 
have not found a single case report in the literature. To date, there is no evidence to 
dispute that there is a need for CRC screening in these patients. If one assumes that 
the risk of colorectal cancer is the same as normal healthy population then these 
patients should be offered colorectal cancer screening.  The conventional FOBT or 
FIT test is clearly inappropriate in these people, colonoscopy, flexible sigmoidoscopy 
or CT colonography are the only currently available options.  Our data suggest that 
the opinion is variable in United Kingdom with the majority recommending 
colonoscopy and equal numbers suggesting flexible sigmoidoscopy and  CT 
colonography.   
Modelling studies have suggested that, where the resource in available,  
colonoscopy is the most effective screening  strategy with the highest life years 
gained and CRCs prevented and the lowest total costs 14. 15. As the number of people 
  
with defunctioned colons is not very large it may be reasonable to suggest that 
colonoscopy is the most appropriate screening test in such cases. 
 
As far as the age of onset for screening in this group is concerned, about half of the  
respondants were not sure;There is variation in the screening age range among the 
bowel screening programmes in the four countries of UK and this may account for 
some ofdifference of opinion about the age of onset of screening.   
Similarly, as far the time interval between the screening tests is concerned majority 
of the practitioners were not sure about the time interval. A biennial time interval 
was used for gFOBT based colorectal cancer screening in the randomised trials that 
demonstrared efficacy6-8. but in the UK Flexible Sigmoidoscopy trial, a single flexible 
sigmoidoscopy offered  between 55-64 years resulted in a a decrease in colorectal 
cancer mortality of 31%.16 However, 30.9% respondents of our study felt that a 5 
yearly interval is reasonable. 
 
In conclusion, this study demonstrates that a screening test for colorectal cancer is 
currently not offered to the majority of people with defunctioned colons. However, 
50% of responders have encountered CRC in such patients. There is a considerable 
variability in opinion regarding the optimal age to commence screening, the time 
interval between screening episodes and the optimal modality to offer for screening 
in such cases. There is an urgent need to clearly define the extent of this important 
clinical problem and provide guidance for how these patients should be managed. 
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Table 1 
 
Colorectal Cancer Screening in People with Defunctioned Colons 
 
Population-based colorectal (bowel) cancer (CRC) screening using faecal occult blood 
tests (FOBT) leads to a reduction in cause-specific mortality. Population-based CRC 
(bowel) screening programmes using FOBT have been introduced across the four 
countries of the UK. The programmes invite all men and women between the age of 
60 and 74 years (50-74 in Scotland) to participate every two years. Following a 
positive test result, individuals are pre-assessed, and then referred for colonoscopy if 
appropriate. If colonoscopy was unsuccessful, then further bowel imaging by barium 
enema or, more recently, CT colonography are carried out. However in patients 
where the colon is defunctioned e.g. due to a pre-existing ileostomy or colostomy 
the use of FOBT is not appropriate. Patients may have a defunctioned colon as 
treatment for functional bowel disorders or due to previous colorectal resections 
with a defunctioning stoma where continuity has not been 
restored. The incidence of malignancy in defuctioned colons is poorly reported and 
these patients present a diagnostic dilemma. Patients are often asymptomatic and 
malignancy can often present at an advanced stage. 
 
Please answer the following questions bearing in mind your own clinical practice or 
colorectal 
cancer screening practice in your area for the people with defunctioned colons of 
adequate length 
(i.e excluding the surveillance of a little rectal stump). 
Colorectal Cancer Screening in People with 
Defunctioned Colons 
1. Have you encountered colorectal cancer in defunctioned colons? 
a. Yes 
b. No 
c. Do not know 
 
  
2. If you have seen or managed patients with colonic cancer in defunctioned 
colons, 
how many such cases you think you have seen? 
a. 0 
b. 1-2 
c. 3-5 
d. 5-10 
 
3. Do you think that a screening test for colorectal cancer in patients/people 
with 
defunctioned colons at appropriate age for screening is done in your area or in your 
clinical practice? 
 
a) Yes 
b) No 
c) Do not know 
 
 
4. What test is offered for colorectal cancer screening in patients/people 
with 
defunctioned colons? 
 
a) Colonoscopy 
b) Flexible sigmoidoscopy 
c) CT colonography 
d) Barium enema 
 
5. With regards to screening of colorectal cancer in the people with 
defunctioned 
colons, what is the age when it is offered (provided there are no other genetic risk 
factors etc for early development of colorectal cancer and patient is fit for 
colonoscopy as well)? 
a) 50-54 years 
  
b) 55-59 years 
c) 60-64 years 
d) 65-69 years 
e) Do not know 
f) Other (please specify) 
 
6. With a normal index investigation, how frequently the follow-up 
investigation is offered? 
a) Never 
b) 3 yearly 
c) 5 yearly 
d) 10 yearly 
e) Do not know 
f) Other (please specify) 
 
7. If a colonoscopy is offered in such cases then how do you prepare the 
colon in 
these patients? 
a) Distal limb lavage if accessible 
b) Enema 
c) Colonoscopy and irrigation system 
d) Do not know 
e) Other (please specify) 
8. Where are you working? 
a) England 
b) Scotland 
c) Wales 
d) Ireland 
e) Other (please specify) 
9. Are you 
a) Consultant 
b) Consultant with special interest in functional bowel disorders 
c) Associate Specialist 
  
d) Staff grade or Speciality Doctor 
e) Other (please specify) 
 
10. How long have you worked in this capacity? 
a) 0-5 years 
b) 5-10 
c) >10 
d) Other (please specify) 
 
